Lihir Medical Centre Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Londolovit Papua New Guinea

Organization Overview

First Clinical Trial
2010
NCT01382004
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Lihir Medical Centre

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Elephantiasis (Phase 3)

Elephantiasis, Filarial (Phase 3)

Filariasis (Phase 3)

Malaria (Phase 3)

Scabies (Phase 3)

Splenomegaly (Phase 3)

Strongyloidiasis (Phase 3)

Trachoma (Phase 3)

Treponemal Infections (Phase 3)

Yaws (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 12